1. Home
  2. PDSB vs SURG Comparison

PDSB vs SURG Comparison

Compare PDSB & SURG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PDSB
  • SURG
  • Stock Information
  • Founded
  • PDSB 2005
  • SURG 2006
  • Country
  • PDSB United States
  • SURG United States
  • Employees
  • PDSB N/A
  • SURG N/A
  • Industry
  • PDSB Biotechnology: Pharmaceutical Preparations
  • SURG Advertising
  • Sector
  • PDSB Health Care
  • SURG Consumer Discretionary
  • Exchange
  • PDSB Nasdaq
  • SURG Nasdaq
  • Market Cap
  • PDSB 43.1M
  • SURG 51.6M
  • IPO Year
  • PDSB N/A
  • SURG N/A
  • Fundamental
  • Price
  • PDSB $1.58
  • SURG $3.06
  • Analyst Decision
  • PDSB Strong Buy
  • SURG Strong Buy
  • Analyst Count
  • PDSB 2
  • SURG 1
  • Target Price
  • PDSB $10.00
  • SURG $8.75
  • AVG Volume (30 Days)
  • PDSB 636.9K
  • SURG 258.6K
  • Earning Date
  • PDSB 05-14-2025
  • SURG 05-13-2025
  • Dividend Yield
  • PDSB N/A
  • SURG N/A
  • EPS Growth
  • PDSB N/A
  • SURG N/A
  • EPS
  • PDSB N/A
  • SURG N/A
  • Revenue
  • PDSB N/A
  • SURG $40,029,467.00
  • Revenue This Year
  • PDSB N/A
  • SURG $103.68
  • Revenue Next Year
  • PDSB N/A
  • SURG $51.08
  • P/E Ratio
  • PDSB N/A
  • SURG N/A
  • Revenue Growth
  • PDSB N/A
  • SURG N/A
  • 52 Week Low
  • PDSB $0.85
  • SURG $1.05
  • 52 Week High
  • PDSB $4.42
  • SURG $4.38
  • Technical
  • Relative Strength Index (RSI)
  • PDSB 66.13
  • SURG 56.08
  • Support Level
  • PDSB $1.24
  • SURG $2.50
  • Resistance Level
  • PDSB $1.66
  • SURG $3.25
  • Average True Range (ATR)
  • PDSB 0.11
  • SURG 0.29
  • MACD
  • PDSB 0.03
  • SURG 0.00
  • Stochastic Oscillator
  • PDSB 69.42
  • SURG 60.87

About PDSB PDS Biotechnology Corporation

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.

About SURG SurgePays Inc.

Surgepays Inc is a fintech company focused on the underbanked community. It provides services to financial technology, telecommunications, and digital media companies. Its operating segment includes Mobile Virtual Network Operators that provide mobile broadband (internet connectivity), voice and SMS text messaging to both subsidized and direct retail prepaid customers through SurgePhone Wireless, LLC and Torch Wireless, LLC; Comprehensive Platform Services provide financial technology and a wireless top-up platform to independently owned convenience stores throughout the country; and Others. It generates the majority of its revenue from the Mobile Virtual Network Operators segment.

Share on Social Networks: